SPS
XFOR icon

Susquehanna Portfolio Strategies’s X4 Pharmaceuticals XFOR Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio XFOR Stock Details XFOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$408K Sell
87,282
-15,317
-15% -$62.8K 0.01% 695
2026
Q1 		$424K Buy
102,599
+59,340
+137% +$222K 0.01% 784
2025
Q4 		$173K Buy
+43,259
New +$157K ﹤0.01% 961

Other funds holding XFOR

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Susquehanna Portfolio Strategies's XFOR Position: Q2 2026 in Review

Susquehanna Portfolio Strategies reduced its X4 Pharmaceuticals (XFOR) stake by 15% in Q2 2026, selling an estimated $62.8K and leaving 87,282 shares worth $408K. The position accounts for 0.01% of the portfolio, ranked #695.

Susquehanna Portfolio Strategies first reported a position in XFOR in Q4 2025 and has held it in 3 quarters since. The position peaked at $424K in Q1 2026. 89 funds tracked by Wall St. Rank hold XFOR as of Q2 2026.

  • Susquehanna Portfolio Strategies held 87,282 shares of X4 Pharmaceuticals worth $408K as of Q2 2026.
  • Susquehanna Portfolio Strategies sold 15,317 X4 Pharmaceuticals shares in Q2 2026, an estimated $62.8K.
  • X4 Pharmaceuticals made up 0.01% of Susquehanna Portfolio Strategies's portfolio in Q2 2026, its #695 holding.
  • Susquehanna Portfolio Strategies first reported a position in X4 Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Susquehanna Portfolio Strategies's X4 Pharmaceuticals position peaked at $424K in Q1 2026.
  • 89 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q2 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.